Advertisement
Advertisement

JUNS

JUNS logo

Jupiter Neurosciences, Inc. Common Stock

5.10
USD
Sponsored
-0.53
-9.45%
Aug 07, 15:56 UTC -4
Closed
exchange

After-Market

5.37

+0.27
+5.20%

Jupiter Neurosciences, Inc. Common Stock Profile

About

Jupiter Neurosciences Inc. is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company's pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer's Disease, Parkinson's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia and MELAS. Jupiter Neurosciences Inc. is based in Jupiter, Florida.

Info & Links

CEO

Christer Ros�n

Headquarters

1001 NORTH US HWY 1, SUITE 504
JUPITER, FL 33477, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

https://jupiterneurosciences.com

Auditor

Cherry Bekaert LLP

Share holders

29

Employees

10

Jupiter Neurosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.04M

Enterprise Value

6.50M

Enterprise Value/EBITDA(ttm)

-0.70

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

19.15%

Operating Margin(ttm)

--

Profit Margin(ttm)

-2763.72%

Return on Equity(ttm)

-1314.62%

Return on Invested Capital(ttm)

-3938.41%

Return on Assets(ttm)

-228.63%

Income Statement

Revenue(ttm)

18.70K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

14.30K

EBITDA(ttm)3

-9.36M

Net Income Available to Common(ttm)

-9.18M

Diluted EPS(ttm)

-0.27

Share Statistics

Beta (5Y Monthly)

1.98

52-Week Change

-94.69%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

36.28M

Dividend Yield

0.00%

Float4

22.28M

% Held by Insiders

38.60%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

2.36M

Total Cash Per Share(mrq)

0.07

Total Debt(mrq)

4.82M

Total Debt/Equity(mrq)

-173.32%

Current Ratio(mrq)

0.51%

Quick Ratio(mrq)

0.48%

Book Value Per Share(mrq)

-0.08

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.04

Free Cash Flow(ytd)

-1.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement